Chester County News and Community Website
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) reported financial results for the fourth quarter and full year ended December 31, 2025, citing growth in sales of its dermatology …
Verrica Pharmaceuticals Reports 2025 Results and YCANTH Sales Growth Read More
WILMINGTON, DE — Global Indemnity Group LLC (Nasdaq: GBLI) reported financial results for the year ended December 31, 2025, citing improved underwriting performance during the year despite losses related to …
Global Indemnity Group Reports 2025 Financial Results Read More
WILMINGTON, DE — Prelude Therapeutics Inc. (Nasdaq: PRLD) reported its financial results for the year ended December 31, 2025, and provided updates on its oncology drug development pipeline, including regulatory …
Prelude Therapeutics Reports 2025 Results and Advances Oncology Pipeline Read More
PHILADELPHIA, PA & NEW YORK, NY — Cohen & Company Inc. (NYSE American: COHN) reported financial results for the fourth quarter and full year ended December 31, 2025, and announced …
Cohen & Company Reports 2025 Results, Declares Dividends Read More
NEWTOWN SQUARE, PA — ArriVent BioPharma Inc. (Nasdaq: AVBP) reported financial results for the year ended December 31, 2025, and said it expects pivotal Phase 3 data for its lung …
ArriVent Reports 2025 Results, Plans Phase 3 Data for Firmonertinib Read More
WILMINGTON, DE — Acorn Energy, Inc. (Nasdaq: ACFN) reported higher revenue and operating income for 2025, driven largely by growth in recurring monitoring services, the company announced Thursday.
Acorn Energy Reports Higher 2025 Revenue on Monitoring Growth Read More
EXTON, PA — Omega Flex, Inc. (NASDAQ: OFLX) reported net sales of $98,296,000 for 2025, down from $101,681,000 in 2024, as lower unit volumes weighed on performance.
Omega Flex Reports Lower Sales and Net Income for 2025 Read More
MALVERN, PA — Ocugen, Inc. (Nasdaq: OCGN) reported fourth quarter and full-year 2025 financial results and provided updates on its clinical pipeline, including completion of enrollment for a Phase 3 …
Ocugen Reports 2025 Results and Clinical Progress Across Gene Therapy Pipeline Read More
PHILADELPHIA, PA — Passage Bio, Inc. (Nasdaq: PASG) reported fourth-quarter and full-year 2025 financial results while providing updates on its clinical program studying PBFT02, a gene therapy candidate for genetic …
Passage Bio Advances Frontotemporal Dementia Trial and Reports 2025 Results Read More
EXTON, PA — Bentley Systems, Incorporated (Nasdaq: BSY) reported full-year revenue of $1.50 billion for 2025, an 11 percent increase from the previous year, as the infrastructure engineering software company …
Bentley Systems Reports $1.5 Billion Revenue for 2025 Read More